Myeloblastic Leukemia (DBCOND0042219)
Identifiers
- Synonyms
- Myeloblastic Leukaemia / Myeloblastic leukemia / Myeloid leukemia / Leukemia, Myeloid / Leukemia myeloid / Non-lymphoblastic leukaemia NOS / Leukemic granulocytic / Non-lymphoblastic leukemia NOS / Unspecified myeloid leukaemia / Unspecified myeloid leukemia / Leukaemia myelogenous / Leukemia myelogenous / Myelocytic leukaemia / Myelocytic leukemia / Leukemia granulocytic NOS / Leukaemia granulocytic NOS / Leukaemia granulocytic / Leukemia granulocytic / Leukaemia myeloid / Myeloid leukemia NOS / Myeloid leukaemia NOS / Myeloid leukaemia
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Daunorubicin An anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia.- DNAtarget
- Cytochrome P450 3A5enzyme
- NADPH--cytochrome P450 reductaseenzyme
- ATP-dependent translocase ABCB1transporter
- Multidrug resistance-associated protein 1transporter
- ATP-binding cassette sub-family C member 6transporter
- ATP-binding cassette sub-family C member 10transporter
- Broad substrate specificity ATP-binding cassette transporter ABCG2transporter
- DNA topoisomerase 2-alphatarget
- DNA topoisomerase 2-betatarget
- Cytochrome P450 1B1enzyme
- Cytochrome P450 3A4enzyme
- Aldo-keto reductase family 1 member B1enzyme
- Carbonyl reductase [NADPH] 1enzyme
- Carbonyl reductase [NADPH] 3enzyme
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT01615809 Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia treatment 2 completed NCT00799799 Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells treatment 1 unknown_status NCT05515029 Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis treatment 3 active_not_recruiting